All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Asia EquityAsia IPOs

US-listed I-Mab readies Shanghai IPO

Shanghai_skyline_575px_Adobe_24Apr2020

Chinese biopharmaceutical company I-Mab is moving ahead with plans for a dual listing in Shanghai, as it looks to broaden its investor base.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree